Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Ductal and Invasive Lobular Breast Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT04790305
What this trial is testing

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

Who this might be right for
Carcinoma BreastTriple-negative Breast CancerInvasive Ductal Carcinoma, Breast
Fudan University 1,072
Very early researchEnded earlyNCT01138553
What this trial is testing

Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer

Who this might be right for
Invasive Breast CancerDuctal Carcinoma in Situ
University of California, San Diego 4
Not applicableStudy completedNCT00898508
What this trial is testing

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

Who this might be right for
Breast Cancer
City of Hope Medical Center 563
Testing effectiveness (Phase 2)Ended earlyNCT06408168
What this trial is testing

Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)

Who this might be right for
Hormone Receptor-positive Human Epidermal Growth Factor 2-negativeMetastatic Invasive LObular Carcinoma
M.D. Anderson Cancer Center 6
Not applicableNot Yet RecruitingNCT07544134
What this trial is testing

Areola Preservation in NSM With Nipple Involvement

Who this might be right for
Breast CancerDuctal Carcinoma In Situ, DCISInvasive Breast Carcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Not applicableStudy completedNCT03437161
What this trial is testing

A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) With Prone Breast Irradiation

Who this might be right for
Breast Cancer
NYU Langone Health 40
Not applicableStudy completedNCT00388115
What this trial is testing

Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
University of California, Davis 15
Large-scale testing (Phase 3)UnknownNCT01126138
What this trial is testing

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

Who this might be right for
Carcinoma, Invasive Ductal, Breast
Chinese Academy of Medical Sciences 200
Not applicableUnknownNCT06158217
What this trial is testing

Effect of Ultrasound Combined With Microbubbles on Blood Perfusion in Invasive Breast Cancer

Who this might be right for
Invasive Breast CancerCavitationPerfusion
Beijing Friendship Hospital 30
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Not applicableStudy completedNCT00694577
What this trial is testing

Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast Cancer

Who this might be right for
Ductal Breast Cancer
Massachusetts General Hospital 324
Testing effectiveness (Phase 2)Study completedNCT00354640
What this trial is testing

Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 11
Not applicableNot Yet RecruitingNCT07527468
What this trial is testing

HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving Surgery

Who this might be right for
Breast CancerDuctal Carcinoma In SituInvasive Lobular Carcinoma+1 more
Hôpital du Valais 228
Not applicableEnded earlyNCT04088435
What this trial is testing

Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast Cancer

Who this might be right for
Breast CancerBreast Cancer, Invasive DuctalInvasive Mammary Carcinoma+2 more
University of Louisville 10
Testing effectiveness (Phase 2)UnknownNCT00723294
What this trial is testing

Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 99
Not applicableUnknownNCT03109522
What this trial is testing

Axillary Reverse Mapping (ARM) Technique

Who this might be right for
Invasive Breast CancerDuctal Carcinoma in Situ of the Breast
McMaster University 130
Testing effectiveness (Phase 2)Study completedNCT00054301
What this trial is testing

Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ or Invasive Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 2
Large-scale testing (Phase 3)UnknownNCT02879513
What this trial is testing

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

Who this might be right for
Invasive Ductal Breast CancerTubular Breast CancerMucinous Breast Cancer+1 more
RenJi Hospital 290
Large-scale testing (Phase 3)Active Not RecruitingNCT02221999
What this trial is testing

Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Ductal Breast Cancer+1 more
RenJi Hospital 250
Not applicableStudy completedNCT01841749
What this trial is testing

Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast

Who this might be right for
Intraductal Carcinoma and Lobular Carcinoma in Situ
Institut Bergonié 228
Next Page